Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
Cammu G, de Kam PJ, De Graeve K, van den Heuvel M, Suy K, Morias K, Foubert L, Grobara P, Peeters P. Cammu G, et al. Among authors: de graeve k, de kam pj. Br J Anaesth. 2010 Oct;105(4):487-92. doi: 10.1093/bja/aeq167. Epub 2010 Jul 14. Br J Anaesth. 2010. PMID: 20630888 Free article. Clinical Trial.
Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers.
de Kam PJ, Nolte H, Good S, Yunan M, Williams-Herman DE, Burggraaf J, Kluft C, Adkinson NF, Cullen C, Skov PS, Levy JH, van den Dobbelsteen DJ, van Heumen ELGM, van Meel FCM, Glassner D, Woo T, Min KC, Peeters PAM. de Kam PJ, et al. Br J Anaesth. 2018 Oct;121(4):758-767. doi: 10.1016/j.bja.2018.05.057. Epub 2018 Jul 13. Br J Anaesth. 2018. PMID: 30236238 Free article. Clinical Trial.
Ara h 2-expressing cucumber mosaic virus-like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals.
Layhadi JA, Starchenka S, De Kam PJ, Palmer E, Patel N, Keane ST, Hikmawati P, Drazdauskaite G, Wu LYD, Filipaviciute P, Parkin RV, Oluwayi K, Rusyn O, Skinner MA, Heath MD, Hewings SJ, Kramer MF, Turner P, Shamji MH. Layhadi JA, et al. Among authors: de kam pj. J Allergy Clin Immunol. 2025 Jan;155(1):153-165. doi: 10.1016/j.jaci.2024.08.010. J Allergy Clin Immunol. 2025. PMID: 39756833
Response to Correspondence to "Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy".
de Kam PJ, Zielen S, Bernstein JA, Berger U, Berger M, Cuevas M, Cypcar D, Fuhr-Horst A, Greisner WA, Jandl M, Laßmann S, Worm M, Matz J, Sher E, Smith C, Steven GC, Mösges R, Shamji MH, DuBuske L, Borghese F, Oluwayi K, Zwingers T, Seybold M, Armfield O, Heath MD, Hewings SJ, Kramer MF, Skinner MA. de Kam PJ, et al. Allergy. 2024 Jun;79(6):1637-1638. doi: 10.1111/all.16104. Epub 2024 Mar 25. Allergy. 2024. PMID: 38525846 No abstract available.
Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy.
de Kam PJ, Zielen S, Bernstein JA, Berger U, Berger M, Cuevas M, Cypcar D, Fuhr-Horst A, Greisner WA, Jandl M, Laßmann S, Worm M, Matz J, Sher E, Smith C, Steven GC, Mösges R, Shamji MH, DuBuske L, Borghese F, Oluwayi K, Zwingers T, Seybold M, Armfield O, Heath MD, Hewings SJ, Kramer MF, Skinner MA. de Kam PJ, et al. Allergy. 2023 Oct;78(10):2756-2766. doi: 10.1111/all.15788. Epub 2023 Jun 27. Allergy. 2023. PMID: 37366581 Clinical Trial.
Dogmas, challenges, and promises in phase III allergen immunotherapy studies.
De Kam PJ, Kramer MF, Shamji MH, Oluwayi K, Heath MD, Jensen-Jarolim E, Berger MH, Berger UE, Graessel A, Sellwood F, Zielen S, Vogelberg C, Zieglmayer P, Mösges R, Klimek L, DuBuske LM, Shreffler WG, Bernstein JA, Kündig TM, Skinner MA. De Kam PJ, et al. World Allergy Organ J. 2021 Sep 28;14(9):100578. doi: 10.1016/j.waojou.2021.100578. eCollection 2021 Sep. World Allergy Organ J. 2021. PMID: 34659627 Free PMC article. Review.
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
Pfaar O, Bergmann KC, Bonini S, Compalati E, Domis N, de Blay F, de Kam PJ, Devillier P, Durham SR, Ellis AK, Gherasim A, Haya L, Hohlfeld JM, Horak F, Iinuma T, Jacobs RL, Jacobi HH, Jutel M, Kaul S, Kelly S, Klimek L, Larché M, Lemell P, Mahler V, Nolte H, Okamoto Y, Patel P, Rabin RL, Rather C, Sager A, Salapatek AM, Sigsgaard T, Togias A, Willers C, Yang WH, Zieglmayer R, Zuberbier T, Zieglmayer P. Pfaar O, et al. Among authors: de kam pj. Allergy. 2021 Dec;76(12):3589-3612. doi: 10.1111/all.14957. Allergy. 2021. PMID: 34028057
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®).
Heath MD, Mohsen MO, de Kam PJ, Carreno Velazquez TL, Hewings SJ, Kramer MF, Kündig TM, Bachmann MF, Skinner MA. Heath MD, et al. Among authors: de kam pj. Front Immunol. 2020 Nov 24;11:594911. doi: 10.3389/fimmu.2020.594911. eCollection 2020. Front Immunol. 2020. PMID: 33324411 Free PMC article. Review.
76 results